tert-butyl 2-(cyclopropylamino)-2-oxoethylcarbamate | 1228594-39-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl 2-(cyclopropylamino)-2-oxoethylcarbamate
• 英文别名: 2-cyclopropylcarbamoylmethyl-carbamic acid tert-butyl ester；tert-butyl N-[2-(cyclopropylamino)-2-oxoethyl]carbamate
• CAS: 1228594-39-5
• 化学式: C₁₀H₁₈N₂O₃
• 分子量: 214.265
• InChiKey: NCADXRUEBISUKI-UHFFFAOYSA-N

物化性质

• 沸点：
  401.8±24.0 °C(Predicted)
• 密度：
  1.11±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  67.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl 2-(cyclopropylamino)-2-oxoethylcarbamate 在 盐酸 、 N-氯代丁二酰亚胺 、 phosphoryloxy trichloride 、 三乙胺 作用下， 以 1,4-二氧六环 、 甲醇 、 乙腈 为溶剂， 反应 6.0h， 生成 4-chloro-N-cyclopropyl-2-(pyridin-3-yl)thiazol-5-amine
  参考文献：
  名称：

  PROCESSES TO PRODUCE CERTAIN 2-(PYRIDINE-3-YL)THIAZOLES

  摘要：

  本文所披露的发明涉及生产某些2-(吡啶-3-基)噻唑作为杀虫噻唑酰胺合成的中间体的过程领域。

  公开号：

  US20130324737A1
• 作为产物：
  描述：

  二碳酸二叔丁酯 在 三乙胺 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 3.0h， 生成 tert-butyl 2-(cyclopropylamino)-2-oxoethylcarbamate
  参考文献：
  名称：

  设计，合成和体外抗甲型流感病毒的新型喹唑啉衍生物在C-4处含有S-乙酰胺和NH-乙酰胺部分。

  摘要：

  由于高致病性和耐药性的流感病毒的出现，迫切需要开发更有效的抗流感药。在此，设计，合成了一系列2,4-二取代的喹唑啉衍生物，并评估了它们对甲型流感病毒的抗病毒活性。九种化合物（10A2，16A，16E，16I，16J，16N，16O，16P和16R）显示针对A型流感病毒（IAV）与IC有效的活性50在低级别微摩尔（μM1.29-9.04）。特别是16e和16r具有良好的抗IAV活性（IC 50分别为1.29μM和3.43μM）和可接受的细胞毒性，并抑制病毒RNA的转录和复制。结合合理的16e PK曲线，这些结果表明它们有望用作进一步研究的潜力。

  DOI：

  10.1016/j.ejmech.2020.112706

文献信息

• 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE
  申请人：van der Stelt Marcelis

  公开号：US20100144723A1

  公开（公告）日：2010-06-10

  The invention relates to A 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione derivative having the general Formula I wherein R 1 is H, (C 1-6 )alkyl (optionally substituted with oxo, OR 4 , COOR 5 , halogen or CN), (C 2-6 )alkenyl, (C 2-6 )alkynyl, (C 3-6 )cycloalkyl or (C 3-6 )cycloalkyl(C 1-3 )alkyl; R 2 and R 2 ′ are independently H or (C 1-3 )alkyl; or R 2 and R 2 ′ form together with the carbon atom to which they are bound a (C 3-5 )cycloalkyl group; R 3 represents H or 1 to 4 F substituents; Y represents or NR 8 R 9 ; X represents CHR 6 , CF 2 , O, S, SO or SO 2 ; R 4 and R 5 are (C 1-6 )alkyl; R 6 is H, OR 7 or CN; R 7 is (C 1-3 )alkyl; R 8 is (C 5-7 )cycloalkyl comprising a heteroatom selected from O, S, SO and SO 2 ; R 9 is H or (C 1-4 )alkyl; o and m represent the ortho or meta position of the substituent Y—CH 2 ; or a pharmaceutically acceptable salt thereof; as well as to the use of said 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione derivatives in the treatment of pain such as for example peri-operative pain, chronic pain, neuropathic pain, cancer pain and pain and spasticity associated with multiple sclerosis.

  该发明涉及具有通式I的1-(联苯基-4-基甲基)咪唑烷二酮衍生物，其中R1为H，(C1-6)烷基（可选地取代为氧代、OR4、COOR5、卤素或CN），(C2-6)烯基，(C2-6)炔基，(C3-6)环烷基或(C3-6)环烷基(C1-3)烷基；R2和R2'独立地为H或(C1-3)烷基；或R2和R2'与它们连接的碳原子一起形成一个(C3-5)环烷基基团；R3代表H或1至4个F取代基；Y代表或NR8R9；X代表CHR6，CF2，O，S，SO或SO2；R4和R5为(C1-6)烷基；R6为H，OR7或CN；R7为(C1-3)烷基；R8为含有来自O、S、SO和SO2的杂原子的(C5-7)环烷基；R9为H或(C1-4)烷基；o和m表示取代基Y-CH2的邻位或间位；或其药学上可接受的盐；以及所述1-(联苯基-4-基甲基)咪唑烷二酮衍生物在治疗疼痛方面的应用，例如围手术期疼痛、慢性疼痛、神经痛、癌症疼痛以及与多发性硬化症相关的疼痛和痉挛。
• 1-(4-(PYRIDIN-2-YL)BENZYL)IMIDAZOLIDINE-2,4-DIONE DERIVATIVES
  申请人：van der Stelt Marcelis

  公开号：US20100144724A1

  公开（公告）日：2010-06-10

  The invention relates to 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivative having the general Formula I wherein R 1 is H, (C 1-6 )alkyl (optionally substituted with oxo, (C 1-3 )alkyloxy, (C 1-3 )alkyloxycarbonyl, halogen or CN), (C 3-6 )cycloalkyl or (C 3-6 )cycloalkyl(C 1-3 )alkyl, each cycloalkyl ring optionally comprising a heteroatom selected from O and S; R 2 and R 3 are independently H or (C 1-3 )alkyl; or R 2 and R 3 form together with the carbon atom to which they are bound a (C 3-5 )cycloalkyl group; R 4 is H or 1 to 3 F substituents; R 5 is H or 1 to 4 F substituents; R 6 and R 7 are independently H or F; X represents R 8 , OR 8 , NR 8 R 9 , R 8 is (C 5-7 )cycloalkyl optionally comprising a heteroatom selected from O, S, SO and SO 2 ; R 9 is H or (C 1-4 )alkyl; R 10 represents 1-3 substituents independently selected from H, (C 1-3 )alkyl, halogen, oxo, CN and CF 3 ; Y is CF 2 , O, S, SO or SO 2 ; or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of said 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives in the treatment of pain such as for example peri-operative pain, chronic pain, neuropathic pain, cancer pain and pain and spasticity associated with multiple sclerosis.

  该发明涉及具有一般式I的1-(4-(吡啶-2-基)苄基)咪唑啉二酮衍生物，其中R1为H，(C1-6)烷基（可选择地取代为氧代、(C1-3)烷氧基、(C1-3)烷氧羰基、卤素或CN），(C3-6)环烷基或(C3-6)环烷基(C1-3)烷基，每个环烷基环可选择包含从O和S中选择的杂原子; R2和R3分别为H或(C1-3)烷基; 或R2和R3与它们连接的碳原子一起形成(C3-5)环烷基基团; R4为H或1至3个F取代基; R5为H或1至4个F取代基; R6和R7分别为H或F; X代表R8，OR8，NR8R9，R8为(C5-7)环烷基，可选择包含从O、S、SO和SO2中选择的杂原子; R9为H或(C1-4)烷基; R10代表1-3个取代基，独立选择自H、(C1-3)烷基、卤素、氧代、CN和CF3; Y为CF2、O、S、SO或SO2;或其药学上可接受的盐，以及包含该类化合物的药物组合物，以及所述1-(4-(吡啶-2-基)苄基)咪唑啉二酮衍生物在治疗疼痛中的用途，例如围手术期疼痛、慢性疼痛、神经性疼痛、癌症疼痛以及与多发性硬化相关的疼痛和痉挛。
• 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
  申请人：N.V. Organon

  公开号：US07960560B2

  公开（公告）日：2011-06-14

  The invention relates to A 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione derivative having the general Formula I wherein R1 is H, (C1-6)alkyl (optionally substituted with oxo, OR4, COOR5, halogen or CN), (C2-6)alkenyl, (C2-6)alkynyl, (C3-6)cycloalkyl or (C3-6)cycloalkyl(C1-3)alkyl; R2 and R2′ are independently H or (C1-3)alkyl; or R2 and R2′ form together with the carbon atom to which they are bound a (C3-5)cycloalkyl group; R3 represents H or 1 to 4 F substituents; Y represents or NR8R9; X represents CHR6, CF2, O, S, SO or SO2; R4 and R5 are (C1-6)alkyl; R6 is H, OR7 or CN; R7 is (C1-3)alkyl; R8 is (C5-7)cycloalkyl comprising a heteroatom selected from O, S, SO and SO2; R9 is H or (C1-4)alkyl; o and m represent the ortho or meta position of the substituent Y—CH2; or a pharmaceutically acceptable salt thereof; as well as to the use of said 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione derivatives in the treatment of pain such as for example peri-operative pain, chronic pain, neuropathic pain, cancer pain and pain and spasticity associated with multiple sclerosis.

  本发明涉及一种具有通式I的1-(联苯基-4-甲基)咪唑啉-2,4-二酮衍生物，其中R1为H、(C1-6)烷基（可选地被氧代、OR4、COOR5、卤素或CN取代）、(C2-6)烯基、(C2-6)炔基、(C3-6)环烷基或(C3-6)环烷基(C1-3)烷基；R2和R2'分别为H或(C1-3)烷基；或R2和R2'与它们所连接的碳原子一起形成一个(C3-5)环烷基；R3代表H或1至4个F取代基；Y代表或NR8R9；X代表CHR6、CF2、O、S、SO或SO2；R4和R5为(C1-6)烷基；R6为H、OR7或CN；R7为(C1-3)烷基；R8为包含从O、S、SO和SO2中选择的杂原子的(C5-7)环烷基；R9为H或(C1-4)烷基；o和m表示取代基Y—CH2的邻位或间位；或其药学上可接受的盐；以及所述1-(联苯基-4-甲基)咪唑啉-2,4-二酮衍生物在治疗疼痛方面的用途，例如围手术期疼痛、慢性疼痛、神经病理性疼痛、癌症疼痛以及与多发性硬化相关的疼痛和痉挛。
• Processes to produce certain 2-(pyridine-3-yl)thiazoles
  申请人：Dow AgroSciences LLC

  公开号：US09108952B2

  公开（公告）日：2015-08-18

  The invention disclosed in this document is related to the field of processes to produce certain 2-(pyridine-3-yl)thiazoles as intermediates for the synthesis of pesticidal thiazole amides.

  本文件所披露的发明涉及生产某些2-(吡啶-3-基)噻唑作为杀虫噻唑酰胺合成的中间体的过程领域。
• US7960560B2
  申请人：——

  公开号：US7960560B2

  公开（公告）日：2011-06-14